A sincere thank you is extended to the AABB TTD Committee and the following supplement authors:
Harvey Alter, MD, National Institutes of Health, Bethesda, MD
Celso Bianco, MD, America’s Blood Centers, Washington, DC
Robin Biswas, MD, Food and Drug Administration, Rockville, MD
Michael P. Busch, MD, PhD, Blood Systems Research Institute, University of California, San Francisco, CA
Ritchard Cable, MD, American Red Cross Blood Services, Farmington, CT
Alain Debrabant, PhD, Food and Drug Administration, Rockville, MD
Eric Delwart, PhD, Blood Systems Research Institute, University of California, San Francisco, CA
Alfred DeMaria, MD, Massachusetts Department of Health and Association of Public Health Laboratories, Jamaica Plain, MA
Roger Y. Dodd, PhD, American Red Cross Blood Services, Rockville, MD
Susan A. Galel, MD, Stanford Blood Center, Palo Alto, CA
Marc Germain, MD, FRCP, PhD, Hema-Quebec, Quebec, Canada
Kay R. Gregory, MS, MT(ASCP)SBB, AABB, Bethesda, MD
Maria D. Guidino, MD, Baxter Healthcare Corporation and Plasma Protein Therapeutics Association, Deerfield, IL
Barbara L. Herwaldt, MD, MPH, Centers for Disease Control and Prevention, Atlanta, GA
F. Blaine Hollinger, MD, Eugene B. Casey Hepatitis Research Center, Baylor College of Medicine, Houston, TX
Pawan Jain, MD, PhD, Food and Drug Administration, Rockville, MD
Louis M. Katz, MD, Mississippi Valley Regional Blood Center, Davenport, IA
Steven Kleinman, MD, University of British Columbia, Vancouver, BC, Canada
Matthew J. Kuehnert, MD, Centers for Disease Control and Prevention, Atlanta, GA
David A. Leiby, PhD, American Red Cross Blood Services, Rockville, MD
Gary J. Levy, MD, LifeShare Blood Centers, Shreveport, LA
Antoinette C. Mattoch, MT(ASCP)SBB, SH, Armed Services Blood Program, Falls Church, VA
Peyton S. Metzel, PhD, Fenwal, Inc., Lake Zurich, IL
Ed Murphy, MD, MPh, Blood Systems Research Institute, University of California, San Francisco, CA
Hira L. Nakhasi, PhD, Food and Drug Administration, Rockville, MD
Phillip Norris, MD, Blood Systems Research Institute, University of California, San Francisco, CA
John Roback, MD, Emory University Hospital, Atlanta, GA
Sean Shadomy, DVM, MPH, Centers for Disease Control and Prevention, Atlanta, GA
Susan L. Stramer, PhD, American Red Cross Blood Services, Gaithersburg, MD
Gary E. Tegtmeier, PhD, Community Blood Center of Greater Kansas City, Kansas City, MO
Silvano Wendel, MD, PhD, Hospital Sirio Libanes, Sao Paulo, Brazil
Return to Emerging Infectious Disease Agents